| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
3 companies
Broadwood Partners, L.P. is a Director, 10% Owner at Lineage Cell Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 44 buys and 0 sells.
Estimated insider holdings value: $582.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 29, 2016 | STAA Staar Surgical Co | 10% Owner | Buy | 14,144 | $5.24 | $74,081.05 | - | |
| Jun 21, 2016 | LCTX Lineage Cell Therapeutics, Inc. | Director, 10% Owner | Buy | 2,732,636 | $2.39 | $6,531,000.04 | +5.8% | |
| May 25, 2016 | STAA Staar Surgical Co | 10% Owner | Buy | 77,842 | $5.16 | $401,729.01 | +0.1% | |
| May 17, 2016 | STAA Staar Surgical Co | 10% Owner | Buy | 9,313 | $5.23 | $48,693.02 | - | |
| May 16, 2016 | STAA Staar Surgical Co | 10% Owner | Buy | 336,210 | $5.49 | $1,847,432.37 | +0.5% | |
| Feb 11, 2016 | STAA Staar Surgical Co | 10% Owner | Buy | 554,066 | $6.01 | $3,329,936.66 | -100% | |
| Feb 9, 2016 | STAA Staar Surgical Co | 10% Owner | Buy | 91,770 | $6.25 | $573,206.61 | +0.2% | |
| Feb 3, 2016 | STAA Staar Surgical Co | 10% Owner | Buy | 121,599 | $6.40 | $778,812.46 | +0.3% | |
| Feb 1, 2016 | STAA Staar Surgical Co | 10% Owner | Buy | 65,983 | $6.48 | $427,634.59 | +0.1% | |
| Jan 27, 2016 | STAA Staar Surgical Co | 10% Owner | Buy | 239,013 | $6.63 | $1,585,799.59 | +0.4% |